Skip to content

Clinical trials

Terminated Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Status: Terminated Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20083
20095
20105
20113
20124
20139
20144
20152
20164
20182
20196
20205
20214
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated67

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4
Incyte Corporation3
Boston Scientific Corporation2
Dana-Farber Cancer Institute2
Gilead Sciences2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Pfizer2
Smith & Nephew, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome67
Pain9
Graft vs Host Disease6
Bronchiolitis Obliterans4
Constipation4
Leukemia4
Opioid-Induced Constipation4
Wounds and Injuries3
Headache2
Hepatitis C2

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.